Table 2. Univariate and multivariate Cox regression models of disease-related features and overall survival (N = 129).
Univariate Cox | Multivariate Cox | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Regression model | Regression model§ | Regression model# | |||||||||
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | ||
Histology | IDC/ILC vs other | 1.20(0.47–3.08) | 0.709 | 1.12(0.42–2.99) | 0.817 | 1.13(0.42–3.00) | 0.810 | ||||
Grade | G3 vs G1-2 | 2.01(1,03–3.93) | 0.042 | 2.06(1.05–4.05) | 0.035 | 2.04(1.04–4.00) | 0.039 | 1.93(0.94–3.93) | 0.072 | 1.89(0.92–3.85) | 0.081 |
Hormone receptors | ER+/PgR+ vs other | 0.77(0.35–1.70) | 0.516 | 0.80(0.36–1.78) | 0.578 | 0.79(0.35–1.78) | 0.571 | ||||
Ki-67 | High vs Low | 1.16(0.61–2.24) | 0.651 | 1.13(0.58–2.24) | 0.072 | 1.18(0.60–2.34) | 0.637 | ||||
TAZ/CTGF | TAZ/CTGF vs other | 1.98(1.03–3.78) | 0.040 | 2.03(1.06–3.90) | 0.033 | 2.10(1.08–4.07) | 0.028 | ||||
YAP/CTGF | YAP/CTGF vs other | 1.97(1.03–3.77) | 0.040 | 2.00(1.04–3.84) | 0.037 | 2.10(1.07–4.09) | 0.030 |
Backward stepwise exclusion.
Adjusted for: Histology, Grade, Hormone receptor status, and Ki-67.